Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 34Neoplasms 10Prostatic Neoplasms 6Neoplasm Metastasis 6Carcinoma, Ovarian Epithelial 5Unspecified Adult Solid Tumor, Protocol Specific 4Ovarian Neoplasms 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms, Male 4Stomach Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Carcinoma, Renal Cell 3Burkitt Lymphoma 3Wilms Tumor 2Testicular Neoplasms 2Teratoma 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Salivary Gland Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Osteosarcoma 2

Interventions

Cetuximab 13Cisplatin 8Radiotherapy, Intensity-Modulated 6Sorafenib 3Radiotherapy 3Paclitaxel 3Erlotinib Hydrochloride 3Docetaxel 3Carboplatin 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3Taxes 2Sirolimus 2Radiation 2Fluorouracil 2Everolimus 2Drug Therapy 2temsirolimus 1sargramostim 1saracatinib 1mercaptoundecahydrododecaborate 1ixabepilone 1cediranib 1advexin 1Zinc Oxide 1Vorinostat 1VTX-2337 1Ultrasonography 1Tobacco Use Cessation Devices 1Soybean Proteins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Tongue Neoplasms × ixabepilone × Clear all
NCT00033618 2013-02-27

Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck

National Cancer Institute (NCI)

Phase 2 Completed
144 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡